GARDEN CITY, N.Y., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on...
APPLE VALLEY, Calif., Sept. 13, 2021 /PRNewswire/ -- Members of United Steelworkers Local 183, which represents roughly 750 workers at Providence St. Mary Medical...
ZEISS and Oak Ridge National Laboratory (ORNL), working together at the Manufacturing Demonstration Facility—a Department of Energy national user facility at ORNL—are developing...
ATLANTA, Sept. 13, 2021 /PRNewswire/ -- Georgia Power's Board of Directors has elected Audrey King as vice president for the company's South Region, effective...
DUBLIN, Sept. 13, 2021 /PRNewswire/ -- The "Glycosylation Analysis Services Market by Company Size, Analytical Techniques and Key Geographical Regions: Industry Trends and...
DUBLIN, Sept. 13, 2021 /PRNewswire/ -- The "Sodium Chloride Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been...
Generálny riaditeľ spoločnosti Winner Medical Ťien-čchüan Li uviedol: "Ekologické povedomie spoločnosti Winner Medical je súčasťou našej DNA od úplného začiatku pred 30 rokmi,...
Baxter International Inc. (“Baxter”) has agreed to acquire Hillrom for $10.5 billion ($156 per share) in a deal expected to close in 2022. After assumption of debt, the total enterprise value of the deal is approximately $12.4 billion. The deal had been rumored for about a month before it was announced.
According to Baxter’s investor presentation, the acquisition is expected to lead to “accelerated product and digital innovation across the care continuum and care settings.”
Patients increasingly want to receive their care at home or nearby, while hospitals and other care providers are increasingly using digital health technologies to expand access, improve quality and lower costs. Baxter and Hillrom are uniting to meet the challenges of a rapidly evolving global healthcare landscape, while also creating significant value for all the stakeholders we serve.
The deal is the latest in a series of moves by Baxter, including extending a multi-year strategic agreement with Amazon Web Services, and acquiring certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife.
MIT engineers, in collaboration with scientists at Cancer Research UK Manchester Institute, have developed a new way to grow tiny replicas of the pancreas,...